Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Willner Capital is a Boca Raton, Florida-based opportunistic investment company that deploys fundamental analysis and event-driven strategies across long and short positions, primarily in small-cap publicly traded equities. The firm appears to invest across multiple sectors rather than operating as a drug developer, healthcare services company, or life sciences platform company. Public descriptions of the business emphasize strategic investing and deep industry analysis, with founder Michael J. Willner highlighting experience in public and private equity investing. Although third-party sources note investments in biotech and pharmaceutical cannabinoid companies, Willner Capital itself is best characterized as an investment firm rather than a healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Willner Capital.